{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:38:36Z","timestamp":1791437916980,"version":"4.3.3"},"reference-count":249,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>EBV is a direct causative agent in around 1.5% of all cancers. The oncogenic properties of EBV are related to its ability to activate processes needed for cellular proliferation, survival, migration, and immune evasion. The EBV latency program is required for the immortalization of infected B cells and involves the expression of non-coding RNAs (ncRNAs), including viral microRNAs. These ncRNAs have different functions that contribute to virus persistence in the asymptomatic host and to the development of EBV-associated cancers. In this review, we discuss the function and potential clinical utility of EBV microRNAs and other ncRNAs in EBV-associated malignancies. This review is not intended to be comprehensive, but rather to provide examples of the importance of ncRNAs.<\/jats:p>","DOI":"10.3390\/cancers13153909","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T08:16:39Z","timestamp":1627978599000},"page":"3909","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["MicroRNA and Other Non-Coding RNAs in Epstein\u2013Barr Virus-Associated Cancers"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-0886","authenticated-orcid":false,"given":"Kin Israel","family":"Notarte","sequence":"first","affiliation":[{"name":"Faculty of Medicine & Surgery, University of Santo Tomas, Manila 1008, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-569X","authenticated-orcid":false,"given":"Suranga","family":"Senanayake","sequence":"additional","affiliation":[{"name":"Mater Misericordiae University Hospital, D07AX57 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-0732","authenticated-orcid":false,"given":"Imee","family":"Macaranas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Surgery, University of Santo Tomas, Manila 1008, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia Marie","family":"Albano","sequence":"additional","affiliation":[{"name":"Research Center for the Natural and Applied Sciences, Molecular Diagnostics Research Group, University of Santo Tomas, Manila 1015, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mundo","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy"},{"name":"Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-3439","authenticated-orcid":false,"given":"Eanna","family":"Fennell","sequence":"additional","affiliation":[{"name":"Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leoncini","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murray","sequence":"additional","affiliation":[{"name":"Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland"},{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK"},{"name":"Institute of Molecular and Translational Medicine, Palack\u00fd University in Olomouc, Hn\u011bvot\u00ednsk\u00e1 5, 779 00 Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis","volume":"8","author":"Georges","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tim.2016.03.008","article-title":"Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers","volume":"24","author":"Pagano","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","article-title":"Molecular mechanisms of viral oncogenesis in humans","volume":"16","author":"Krump","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e01718-16","DOI":"10.1128\/JVI.01718-16","article-title":"Epstein-Barr virus LMP1-mediated oncogenicity","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/pir.32.9.375","article-title":"Epstein-Barr virus","volume":"32","author":"Jenson","year":"2011","journal-title":"Pediatr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Al-Sadeq, D.W., Ali, N.H., Pintus, G., Abou-Saleh, H., and Nasrallah, G.K. (2018). Epstein-barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: An update. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00211"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein\u2013Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1038\/emm.2014.109","article-title":"EBV and human cancer","volume":"47","author":"Ko","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12656","article-title":"Epstein\u2013Barr virus in the pathogenesis of oral cancers","volume":"24","author":"Guidry","year":"2018","journal-title":"Oral Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/femsre\/fuz023","article-title":"Epithelial cell infection by Epstein\u2013Barr virus","volume":"43","author":"Chen","year":"2019","journal-title":"FEMS MicroBiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells","volume":"9","author":"Tugizov","year":"2003","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shannon-Lowe, C., and Rowe, M. (2011). Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001338"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00430-018-0570-1","article-title":"Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis","volume":"208","author":"Yin","year":"2019","journal-title":"Med. MicroBiol. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gr.083550.108","article-title":"The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer","volume":"19","author":"Fernandez","year":"2009","journal-title":"Genome Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kang, M.S., and Kieff, E. (2015). Epstein-Barr virus latent genes. Exp. Mol. Med., 47.","DOI":"10.1038\/emm.2014.84"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhao, M., Nanbo, A., Sun, L., and Lin, Z. (2019). Extracellular vesicles in Epstein-Barr virus\u2019 life cycle and pathogenesis. Microorganisms, 7.","DOI":"10.3390\/microorganisms7020048"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.02781-14","article-title":"Cellular differentiation regulator BLIMP1 induces Epstein\u2013Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters","volume":"89","author":"Reusch","year":"2015","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1073\/pnas.83.23.9006","article-title":"Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization","volume":"83","author":"Howe","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1099\/0022-1317-73-12-3169","article-title":"Expression of genes for the Epstein-Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt\u2019s lymphoma cells: Effects of interferon treatment","volume":"73","author":"Clarke","year":"1992","journal-title":"J. Gen. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910460509","article-title":"Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin\u2019s disease","volume":"46","author":"Wu","year":"1990","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.78.2.805","article-title":"Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus","volume":"78","author":"Lerner","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.91.8.3463","article-title":"The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes","volume":"91","author":"Toczyski","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0300-9084(94)90081-7","article-title":"Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs","volume":"76","author":"Clemens","year":"1994","journal-title":"Biochimie"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1128\/JVI.01873-15","article-title":"Epstein\u2013Barr viruses (EBVs) deficient in EBV-encoded RNAs have higher levels of latent membrane protein 2RNAexpression in lymphoblastoid cell lines and efficiently establish persistent infections in humanized mice","volume":"89","author":"Gregorovic","year":"2015","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2015.01.015","article-title":"EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41598-017-18638-7","article-title":"Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of herpesvirus telomerase RNA (vTR) in virus-induced tumor formation","volume":"8","author":"Kheimar","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","article-title":"MicroRNA-cancer connection: The beginning of a new tale","volume":"66","author":"Calin","year":"2006","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: Biogenesis; Function and Role in Cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer","volume":"23","author":"Croce","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12967-019-2086-x","article-title":"Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study","volume":"17","author":"Moi","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Ji","year":"2003","journal-title":"Oncogene"},{"key":"ref_40","first-page":"169","article-title":"MALAT-1: A long non-coding RNA and its important 3\u2019 end functional motif in colorectal cancer metastasis","volume":"39","author":"Xu","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Reddy, K.B. (2015). MicroRNA (miRNA) in cancer. Cancer Cell Int., 15.","DOI":"10.1186\/s12935-015-0185-1"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: Pathology and biology","volume":"53","author":"Mathas","year":"2016","journal-title":"Semin. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin\u2019s lymphoma","volume":"9","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-B-RelA activation is required for proliferation and survival of Hodgkin\u2019s disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-\u03baB maintains high expression of a characteristic gene network; including CD40; CD86; and a set of antiapoptotic genes in Hodgkin\/Reed-Sternberg cells","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1; which simulates an activated CD40 receptor","volume":"17","author":"Kilger","year":"1998","journal-title":"EMBO J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: Transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V84.11.3792.bloodjournal84113792","article-title":"Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin\u2019s disease","volume":"84","author":"Murray","year":"1994","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711660102","article-title":"Immunohistochemical demonstration of the Epstein\u2013Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin\u2019s disease","volume":"166","author":"Murray","year":"1992","journal-title":"J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","article-title":"Immunohistochemical detection of the Epstein-Barr Virus-encoded latent membrane protein 2A in Hodgkin\u2019s disease and infectious mononucleosis","volume":"90","author":"Niedobitek","year":"1997","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.200366597","article-title":"Tonsillar memory B cells; latently infected with Epstein-Barr virus; express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors","volume":"97","author":"Babcock","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0024-3205(99)00214-3","article-title":"A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells","volume":"65","author":"Babcock","year":"1999","journal-title":"Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt\u2019s lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Qiu, J., Cosmopoulos, K., Pegtel, M., Hopmans, E., Murray, P., Middeldorp, J., Shapiro, M., and Thorley-Lawson, D.A. (2011). A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002193"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Navari, M., Etebari, M., Ibrahimi, M., Leoncini, L., and Piccaluga, P.P. (2018). Pathobiologic roles of Epstein-Barr virus-encoded microRNAs in human lymphomas. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041168"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JVI.01528-10","article-title":"Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their Regulation","volume":"85","author":"Amoroso","year":"2011","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cam4.1006","article-title":"Next-generation sequencing of miRNAs in clinical samples of Epstein\u2013Barr virus-associated B-cell lymphomas","volume":"6","author":"Sakamoto","year":"2017","journal-title":"Cancer Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.18632\/oncotarget.14380","article-title":"The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exphem.2015.12.007","article-title":"High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma","volume":"44","author":"Marques","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Delecluse, S., Yu, J., Bernhardt, K., Haar, J., Poirey, R., Tsai, M.H., Kiblawi, R., Kopp-Schneider, A., Schnitzler, P., and Zeier, M. (2019). Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222847"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/nar\/gkm1080","article-title":"Epstein-Barr virus-encoded microRNA miR-BART2 downregulates the viral DNA polymerase BALF5","volume":"36","author":"Barth","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1182\/blood-2010-09-307710","article-title":"Downregulation of BLIMP1\u03b1 by the EBV oncogene; LMP-1; disrupts the plasma cell differentiation program and prevents viral replication in B cells: Implications for the pathogenesis of EBV-associated B-cell lymphomas","volume":"117","author":"Vrzalikova","year":"2011","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Chen, Y., Fachko, D., Ivanov, N.S., Skinner, C.M., and Skalsky, R.L. (2019). Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007535"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.2384","article-title":"The Epstein-Barr virus oncoprotein; latent membrane protein-1; reprograms germinal centre B cells towards a Hodgkin\u2019s Reed-Sternberg-like phenotype","volume":"216","author":"Vockerodt","year":"2008","journal-title":"J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1073\/pnas.0914843107","article-title":"Functional delivery of viral miRNAs via exosomes","volume":"107","author":"Pegtel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1182\/blood-2017-07-794529","article-title":"Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma","volume":"131","author":"Higuchi","year":"2018","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: A correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","article-title":"Lopez-Guillermo, A.; Artells, R.; et al. MicroRNA expression profiling in classic Hodgkin lymphoma","volume":"111","author":"Navarro","year":"2008","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.12390","article-title":"MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma","volume":"162","author":"Montalban","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s13277-014-2802-3","article-title":"Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma","volume":"36","author":"Dhiab","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood.V122.21.628.628","article-title":"Long non-coding RNAs are commonly deregulated in Hodgkin lymphoma","volume":"122","author":"Tayari","year":"2013","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ajpath.2016.05.011","article-title":"Long noncoding RNA expression profiling in normal B-cell subsets and Hodgkin lymphoma reveals Hodgkin and Reed-Sternberg cell-specific long noncoding RNAs","volume":"186","author":"Tayari","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_77","first-page":"6219","article-title":"Long non-coding RNA NEAT1 regulates Hodgkin\u2019s lymphoma cell proliferation and invasion via miR-448 mediated regulation of DCLK1","volume":"24","author":"Fan","year":"2020","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.5114\/aoms.2020.98839","article-title":"Construction of relapse-related lncRNA-mediated ceRNA networks in Hodgkin lymphoma","volume":"16","author":"Liang","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_79","first-page":"1825","article-title":"Long non-coding RNA H19 promotes proliferation of Hodgkin\u2019s lymphoma via AKT pathway","volume":"23","author":"Wang","year":"2018","journal-title":"J. Buon"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: Clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"Magrath","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(20)30126-5","article-title":"HIV-associated Burkitt lymphoma","volume":"7","author":"Murphy","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.24655","article-title":"B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression","volume":"126","author":"Leucci","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","article-title":"MiRNA profiling in B non-Hodgkin lymphoma: A MYC-related miRNA profile characterizes Burkitt lymphoma","volume":"149","author":"Robertus","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"107356","DOI":"10.18632\/oncotarget.22219","article-title":"MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma","volume":"8","author":"Ambrosio","year":"2017","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Oduor, C.I., Kaymaz, Y., Chelimo, K., Otieno, J.A., Ong\u2019echa, J.M., Moormann, A.M., and Bailey, J.A. (2017). Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3711-9"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"De Falco, G., Ambrosio, M.R., Fuligni, F., Onnis, A., Bellan, C., Rocca, B.J., Navari, M., Etebari, M., Mundo, L., and Gazaneo, S. (2015). Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1661-7"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/leu.2011.156","article-title":"The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma","volume":"25","author":"Lenze","year":"2011","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-016-2653-7","article-title":"miR-17-92 cluster components analysis in Burkitt lymphoma: Overexpression of miR-17 is associated with poor prognosis","volume":"95","author":"Robaina","year":"2016","journal-title":"Ann. Hematol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cbin.10039","article-title":"c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level","volume":"37","author":"Liu","year":"2013","journal-title":"Cell Biol. Int."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Onnis, A., De Falco, G., Antonicelli, G., Onorati, M., Bellan, C., Sherman, O., Sayed, S., and Leoncini, L. (2010). Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012960"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"MicroRNA let-7a downregulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells","volume":"67","author":"Sampson","year":"2007","journal-title":"Cancer Res."},{"key":"ref_94","first-page":"89","article-title":"MicroRNA-21 and microRNA-155 promote the progression of Burkitt\u2019s lymphoma by the PI3K\/AKT signaling pathway","volume":"13","author":"Han","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ijc.24223","article-title":"Epstein-Barr virus and the pathogenesis of Burkitt\u2019s lymphoma: More questions than answers","volume":"124","author":"Bornkamm","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt\u2019s lymphoma cells","volume":"6","author":"Rowe","year":"1987","journal-title":"EMBO J."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Abate, F., Ambrosio, M., Mundo, L., Laginestra, M., Fuligni, F., Rossi, M., Zairis, S., Gazaneo, S., De Falco, G., and Lazzi, S. (2015). Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005158"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kelly, G.L., Long, H.M., Stylianou, J., Thomas, W.A., Leese, A., Bell, A.I., Bornkamm, G.W., Mautner, J., Rickinson, A.B., and Rowe, M. (2009). An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp\/BHRF1 Link. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000341"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2014.10.030","article-title":"Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral Mrna","volume":"474","author":"Tierney","year":"2015","journal-title":"Virology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","article-title":"Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis","volume":"74","author":"Ruf","year":"2000","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2017.10.095","article-title":"EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells","volume":"494","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Onnis, A., Navari, M., Antonicelli, G., Morettini, F., Mannucci, S., De Falco, G., Vigorito, E., and Leoncini, L. (2012). Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J., 2.","DOI":"10.1038\/bcj.2012.29"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/rmv.363","article-title":"The role of Epstein\u2013Barr virus-encoded small RNAs (EBERs) in oncogenesis","volume":"12","author":"Nanbo","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.critrevonc.2019.01.014","article-title":"The roles of EBV-encoded microRNAs in EBV-associated tumors","volume":"135","author":"Dong","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Oduor, C.I., Movassagh, M., Kaymaz, Y., Chelimo, K., Otieno, J., Ong\u2019echa, J.M., Moormann, A.M., and Bailey, J.A. (2017). Human and Epstein-Barr virus miRNA profiling as predictive biomarkers. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00501"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","article-title":"The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines","volume":"386","author":"Pratt","year":"2009","journal-title":"Virology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/onc.2013.71","article-title":"Epstein-Barr virus maintains lymphomas via its miRNAs","volume":"33","author":"Vereide","year":"2014","journal-title":"Oncogene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3892\/mmr.2017.6173","article-title":"EBV-BART-6-3p and cellular microRNA197 compromise the immune defense of host cells in EBV-positive Burkitt lymphoma","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.12659\/MSM.897306","article-title":"Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma","volume":"22","author":"Zhou","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/oncotarget.4399","article-title":"Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas","volume":"7","author":"Piccaluga","year":"2016","journal-title":"Oncotarget"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-9378-9-12","article-title":"The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma","volume":"9","author":"Ambrosio","year":"2014","journal-title":"Infect. Agent Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/emboj.2012.63","article-title":"EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency","volume":"31","author":"Riley","year":"2012","journal-title":"EMBO J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.12659\/MSM.897417","article-title":"Circulating microRNA-21; microRNA-23a; and microRNA-125b as biomarkers for diagnosis and prognosis of Burkitt lymphoma in children","volume":"22","author":"Li","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"E5261","DOI":"10.1073\/pnas.1505753112","article-title":"MINCR is a MYC-induced lncRNA able to modulate MYC\u2019s transcriptional network in Burkitt lymphoma cells","volume":"112","author":"Doose","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","first-page":"1225","article-title":"Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation","volume":"18","author":"Zheng","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/mmr.2020.11785","article-title":"Knockdown of long non coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF \u03b21 signaling pathway","volume":"23","author":"Mao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/1535370219860207","article-title":"LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling","volume":"244","author":"Deng","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1615\/JEnvironPatholToxicolOncol.2019028282","article-title":"Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression","volume":"38","author":"Ji","year":"2019","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.2147\/CMAR.S248698","article-title":"Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a\/EIF4E Axis","volume":"12","author":"Guo","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"27839","DOI":"10.18632\/oncotarget.15711","article-title":"The effects of DLEU1 gene expression in Burkitt lymphoma (BL): Potential mechanism of chemoimmunotherapy resistance in BL","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/bcj.2012.1","article-title":"MicroRNA signatures in B-cell lymphomas","volume":"2","author":"Mollejo","year":"2012","journal-title":"Blood Cancer J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","article-title":"Diffuse large B-cell lymphoma: R-CHOP failure\u2014what to do?","volume":"2016","author":"Coiffier","year":"2016","journal-title":"Am. Soc. Hematol. Educ. Program"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","article-title":"MicroRNAs are Independent Predictors of Outcome in Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP","volume":"17","author":"Alencar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma","volume":"121","author":"Lawrie","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Bradshaw, G., Sutherland, H.G., Haupt, L.M., and Griffiths, L.R. (2016). Dysregulated MicroRNA expression profiles and potential cellular; circulating and polymorphic biomarkers in non-Hodgkin lymphoma. Genes, 7.","DOI":"10.3390\/genes7120130"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","article-title":"MicroRNA profiling in Epstein-Barr virus-associated B-cell lymphoma","volume":"39","author":"Imig","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1128\/JVI.07056-11","article-title":"The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells","volume":"86","author":"Forte","year":"2012","journal-title":"J. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/rna.4.3.5206","article-title":"Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a","volume":"4","author":"Motsch","year":"2007","journal-title":"RNA Biol."},{"key":"ref_137","first-page":"9725","article-title":"Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma","volume":"15","author":"Wu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/leu.2011.189","article-title":"Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma","volume":"26","author":"Vargiu","year":"2012","journal-title":"Leukemia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00277-014-2111-3","article-title":"Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients","volume":"93","author":"Song","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.prp.2018.08.006","article-title":"Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis","volume":"214","author":"Dousti","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"23228","DOI":"10.18632\/oncotarget.15571","article-title":"Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3892\/or.2017.5821","article-title":"Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma","volume":"38","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.7754\/Clin.Lab.2017.170605","article-title":"A Pooled Analysis of The Clinical Utilities of Long Non-Coding RNA Based Molecular Signature for Diffuse Large B Cell Lymphoma","volume":"63","author":"Xu","year":"2017","journal-title":"Clin. Lab."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12943-017-0580-4","article-title":"Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13073-015-0230-7","article-title":"Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma","volume":"7","author":"Verma","year":"2015","journal-title":"Genome Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"27842","DOI":"10.1038\/srep27842","article-title":"A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1111\/jcmm.14601","article-title":"Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p\/PIM1 axis","volume":"23","author":"Zhu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-019-1886-5","article-title":"LncRNA SNHG14\/miR-5590-3p\/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1\/PD-L1 checkpoint","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.3892\/mmr.2016.5190","article-title":"Elevated RNA expression of long non-coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma","volume":"13","author":"Yan","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/CBM-160221","article-title":"Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma","volume":"23","author":"Deng","year":"2018","journal-title":"Cancer Biomark."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"34374","DOI":"10.18632\/oncotarget.16163","article-title":"The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","article-title":"LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Zhao, J., Su, L., and Jiang, J. (2020). Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p. Med. Sci. Monit., 25.","DOI":"10.12659\/MSM.922810"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-015-0350-9","article-title":"Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity","volume":"16","author":"Peng","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.05.006","article-title":"Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma","volume":"70","author":"Ahmadvand","year":"2018","journal-title":"Leuk. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/etm.2012.502","article-title":"Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed\/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma","volume":"3","author":"Zhong","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2014.04.002","article-title":"Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"45","author":"Wu","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"17161","DOI":"10.1038\/s41598-019-52985-x","article-title":"Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models","volume":"9","author":"Beheshti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_159","first-page":"15019","article-title":"miR-21 expression predicts prognosis in diffuse large B-cell lymphoma","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2015-11-680462","article-title":"miR-181a negatively regulates NF-\u03baB signaling and affects activated B-cell-like diffuse large B-cell lymphoma pathogenesis","volume":"127","author":"Kozloski","year":"2016","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: More than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"El-Sharkawy, A., Al Zaidan, L., and Malki, A. (2018). Epstein-Barr virus-associated malignancies: Roles of viral oncoproteins in carcinogenesis. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00265"},{"key":"ref_163","first-page":"581","article-title":"Epstein-Barr virus and nasopharyngeal carcinoma","volume":"33","author":"Young","year":"2014","journal-title":"Chin. J. Cancer"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anl.2006.09.025","article-title":"Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma","volume":"34","author":"Yoshizaki","year":"2007","journal-title":"Auris Nasus Larynx"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"24291","DOI":"10.18632\/oncotarget.4552","article-title":"EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10735-013-9503-x","article-title":"Expression of LINC00312; a long intergenic non-coding RNA; is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma","volume":"44","author":"Zhang","year":"2013","journal-title":"J. Mol. Histol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"41166","DOI":"10.18632\/oncotarget.17083","article-title":"Serum long non-coding RNAs MALAT1; AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Chen, S.J., Chen, G.H., Chen, Y.H., Liu, C.Y., Chang, K.P., Chang, Y.S., and Chen, H.C. (2010). Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012745"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1101\/gad.1761509","article-title":"Selective stabilization of mammalian microRNAs by 3\u2032 adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2","volume":"23","author":"Katoh","year":"2009","journal-title":"Genes Dev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1101\/gr.077578.108","article-title":"In-depth characterization of the microRNA transcriptome in a leukemia progression model","volume":"18","author":"Kuchenbauer","year":"2008","journal-title":"Genome Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fgene.2019.00939","article-title":"EBV-miR-BART7-3p imposes stemness in nasopharyngeal carcinoma cells by suppressing SMAD7","volume":"10","author":"Cai","year":"2019","journal-title":"Front. Genet."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/onc.2014.341","article-title":"EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN","volume":"34","author":"Cai","year":"2015","journal-title":"Oncogene"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2013.05.008","article-title":"EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma","volume":"436","author":"Ye","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1038\/ncomms8353","article-title":"Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.18632\/oncotarget.3046","article-title":"Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"BSR20190415","DOI":"10.1042\/BSR20190415","article-title":"EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM\/ATR signaling pathway","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Hsu, C.Y., Yi, Y.H., Chang, K.P., Chang, Y.S., Chen, S.J., and Chen, H.C. (2014). The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003974"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"41766","DOI":"10.18632\/oncotarget.6155","article-title":"EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC","volume":"6","author":"Yan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/0008-5472.CAN-19-0334","article-title":"Epstein-Barr virus miRNA BART2-5p promotes metastasis of nasopharyngeal carcinoma by suppressing RND3","volume":"80","author":"Jiang","year":"2020","journal-title":"Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"144243","DOI":"10.1016\/j.gene.2019.144243","article-title":"MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis","volume":"727","author":"Zou","year":"2020","journal-title":"Gene"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hed.25544","article-title":"Detection of Epstein-Barr virus (EBV)\u2014encoded microRNAs in plasma of patients with nasopharyngeal carcinoma","volume":"41","author":"Gao","year":"2019","journal-title":"Head Neck."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3233\/CBM-190160","article-title":"Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis","volume":"27","author":"Wu","year":"2020","journal-title":"Cancer Biomark."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1923-2","article-title":"Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma","volume":"17","author":"Wen","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Polakovicova, I., Jerez, S., Wichmann, I.A., Sandoval-B\u00f3rquez, A., Carrasco-V\u00e9liz, N., and Corval\u00e1n, A.H. (2018). Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastic cancers. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00636"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/v4123420","article-title":"Epstein-barr virus (EBV)-associated gastric carcinoma","volume":"4","author":"Iizasa","year":"2012","journal-title":"Viruses"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/cancers6042259","article-title":"Epstein-Barr virus in gastric carcinoma","volume":"6","author":"Nishikawa","year":"2014","journal-title":"Cancers"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.3748\/wjg.v20.i21.6448","article-title":"Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments","volume":"20","author":"Yau","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1200\/JCO.2004.08.061","article-title":"EBV-positive gastric adenocarcinomas: A distinct clinicopathologic entity with a low frequency of lymph node involvement","volume":"22","author":"Middeldorp","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Yanagi, A., Nishikawa, J., Shimokuri, K., Shuto, T., Takagi, T., Takagi, F., Kobayashi, Y., Yamamoto, M., Miura, O., and Yanai, H. (2019). Clinicopathologic Characteristics of Epstein-Barr Virus-Associated Gastric Cancer Over the Past Decade in Japan. Microorganisms, 7.","DOI":"10.3390\/microorganisms7090305"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/PAS.0000000000001521","article-title":"An Integrative Morphomolecular Classification System of Gastric Carcinoma with Distinct Clinical Outcomes","volume":"44","author":"Tsai","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_192","first-page":"73","article-title":"Epstein\u2013Barr virus in gastro-esophageal adenocarcinomas\u2013single center experiences in the context of current literature","volume":"26","author":"Genitsch","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e11769","DOI":"10.1097\/MD.0000000000011769","article-title":"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis","volume":"97","author":"Lee","year":"2018","journal-title":"Medicine"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.5114\/aoms.2019.86101","article-title":"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A meta-analysis and experimental validation","volume":"16","author":"Zhang","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"32925","DOI":"10.18632\/oncotarget.9076","article-title":"Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers","volume":"7","author":"Derks","year":"2016","journal-title":"Oncotarget"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","article-title":"Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): A multicentre, open-label, phase 1b trial","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein","volume":"91","author":"Imai","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"6021934","DOI":"10.1155\/2016\/6021934","article-title":"Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis","volume":"2016","author":"Giudice","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/sj.onc.1210496","article-title":"Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways","volume":"26","author":"Wood","year":"2007","journal-title":"Oncogene"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Sivachandran, N., Sarkari, F., and Frappier, L. (2008). Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000170"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4239","article-title":"Constitutive activation of distinct NF-\u03baB signals in EBV-associated nasopharyngeal carcinoma","volume":"231","author":"Chung","year":"2013","journal-title":"J. Pathol."},{"key":"ref_202","first-page":"7062","article-title":"Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA","volume":"63","author":"Iwakiri","year":"2003","journal-title":"Cancer Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.onc.1208357","article-title":"Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines","volume":"24","author":"Iwakiri","year":"2005","journal-title":"Oncogene"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-230X(10)07004-1","article-title":"Role of EBERs in the pathogenesis of EBV infection","volume":"107","author":"Iwakiri","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-09-4620","article-title":"Downregulation of MicroRNA-200 in EBV-associated gastric carcinoma","volume":"70","author":"Shinozaki","year":"2010","journal-title":"Cancer Res."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.03639-14","article-title":"Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis","volume":"89","author":"Kunita","year":"2015","journal-title":"J. Virol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"e01022-18","DOI":"10.1128\/JVI.01022-18","article-title":"Epstein-Barr virus microRNA miR-BART5-3p inhibits p53 expression","volume":"92","author":"Zheng","year":"2018","journal-title":"J. Virol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","article-title":"The Epstein\u2013Barr Virus BART microRNAs target the pro-apoptotic protein Bim","volume":"412","author":"Marquitz","year":"2011","journal-title":"Virology"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.canlet.2014.10.023","article-title":"Epstein\u2013Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD","volume":"356","author":"Kim","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13402-020-00538-0","article-title":"EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway","volume":"43","author":"Dong","year":"2020","journal-title":"Cell Oncol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/labinvest.2016.33","article-title":"Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns","volume":"96","author":"Treece","year":"2016","journal-title":"Lab. Investig."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"80990","DOI":"10.18632\/oncotarget.13167","article-title":"SNHG8 is identified as a key regulator of epstein-barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s10120-020-01059-3","article-title":"Epstein\u2013Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3\/pSTAT3 modulation; worsening clinical outcomes of PD-L1-positive gastric carcinomas","volume":"23","author":"Yoon","year":"2020","journal-title":"Gastric Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"14988","DOI":"10.18632\/oncotarget.14744","article-title":"High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Pandya, D., Mariani, M., He, S., Andreoli, M., Spennato, M., Dowell-Martino, C., Fiedler, P., and Ferlini, C. (2015). Epstein-Barr virus microRNA expression increases aggressiveness of solid malignancies. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136058"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000479749","article-title":"Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway","volume":"9","author":"Lu","year":"2017","journal-title":"J. Innate Immun."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","article-title":"EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-\u03b3-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma","volume":"184","author":"Huang","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Ungerleider, N., Bullard, W., Kara, M., Wang, X., Roberts, C., Renne, R., Tibbetts, S., and Flemington, E.K. (2021). EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009217"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20160248","article-title":"Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing","volume":"213","author":"Tagawa","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/modpathol.2016.202","article-title":"Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1 + immune cells in Epstein-Barr virus-associated gastric cancer: The prognostic implications","volume":"30","author":"Saito","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 upregulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-l1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: Implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"13060","DOI":"10.18632\/oncotarget.7421","article-title":"Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1479-5876-7-73","article-title":"Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology","volume":"7","author":"Gu","year":"2009","journal-title":"J. Transl. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"djx007","DOI":"10.1093\/jnci\/djx007","article-title":"Current state of PCR-based Epstein-barr virus DNA testing for nasopharyngeal cancer","volume":"109","author":"Kim","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1349-7006.2004.tb03241.x","article-title":"Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients","volume":"95","author":"Kondo","year":"2004","journal-title":"Cancer Sci."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hon.2360","article-title":"Circulating Epstein-Barr virus\u2013encoded micro-RNAs as potential biomarkers for nasal natural killer\/T-cell lymphoma","volume":"35","author":"Komabayashi","year":"2017","journal-title":"Hematol. Oncol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1002\/ijc.29206","article-title":"Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment","volume":"136","author":"Zhang","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Hirai, N., Wakisaka, N., Kondo, S., Aga, M., Moriyama-Kita, M., Ueno, T., Nakanishi, Y., Endo, K., Sugimoto, H., and Murono, S. (2016). Potential interest in circulating miR-BART17-5p as a post-treatment biomarker for prediction of recurrence in Epstein-Barr virus-related nasopharyngeal carcinoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163609"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1002\/ijc.31642","article-title":"Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma","volume":"143","author":"Jiang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/cas.14381","article-title":"Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma","volume":"111","author":"Lu","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/ijc.31967","article-title":"Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections","volume":"144","author":"Ramayanti","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/ijc.32656","article-title":"Systematic comparison of plasma EBV DNA; anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma","volume":"146","author":"Tan","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.18632\/oncotarget.6649","article-title":"Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_238","first-page":"3201","article-title":"Overexpression of epstein-barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma","volume":"32","author":"Chan","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.gt.3303055","article-title":"Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs","volume":"15","author":"Choy","year":"2008","journal-title":"Gene Ther."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Wang, X., Xiang, Z., Liu, Y., Huang, C., Pei, Y., Wang, X., Zhi, H., Wong, W.H., Wei, H., and Ng, I.O. (2020). Exosomes derived from V\u03b42-T cells control Epstein-Barr virus-associated tumors and induce T cell antitumor immunity. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.aaz3426"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1242\/jcs.085050","article-title":"Mir-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma","volume":"124","author":"Deng","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Ungerleider, N., Concha, M., Lin, Z., Roberts, C., Wang, X., and Cao, S. (2019). The Epstein-Barr virus circRNAome. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007206"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"E8737","DOI":"10.1073\/pnas.1811728115","article-title":"Circular DNA tumor viruses make circular RNAs","volume":"115","author":"Toptan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.trecan.2018.09.005","article-title":"Connivance, complicity, or collusion? The role of noncoding RNAs in promoting gamma herpesvirus tumorigenesis","volume":"4","author":"Bullard","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/21655979.2019.1679698","article-title":"Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis","volume":"10","author":"Qiao","year":"2019","journal-title":"Bioengineered"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"657036","DOI":"10.3389\/fmicb.2021.657036","article-title":"Role of virally encoded circular RNAs in the pathogenicity of human oncogenic viruses","volume":"12","author":"Avilala","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e49689","DOI":"10.15252\/embr.201949689","article-title":"Epstein-Barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer","volume":"21","author":"Gong","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.2147\/CMAR.S218967","article-title":"Knockdown of EBV-encoded circRNA circRPMS1 suppresses nasopharyngeal carcinoma cell proliferation and metastasis through sponging multiple miRNAs","volume":"11","author":"Liu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12985-020-01308-y","article-title":"Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis","volume":"17","author":"Zhang","year":"2020","journal-title":"Virol. J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/15\/3909\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:39:31Z","timestamp":1760164771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/15\/3909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":249,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["cancers13153909"],"URL":"https:\/\/doi.org\/10.3390\/cancers13153909","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}